The EU Court of Justice dismisses the appeals of several manufacturers of medicines against the General Court’ s judgment upholding the Commission’s pay-for-delay infringement decision (Lundbeck)

Click here to read the full article online

On 25 March 2021, the Court of Justice of the European Union (“CJEU”) dismissed the appeals by Lundbeck, Merck KGaA (and Generics UK), Arrow, Alpharma (and Xellia) and Ranbaxy, against the General Court’s (“GC”) judgment upholding the European Commission’s (“Commission”) 2013 pay-for-delay infringement decision.